CompletedPHASE2, PHASE3NCT03915366

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Studying Primary genito-urinary tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Universitario 12 de Octubre
Principal Investigator
Cinta Moraleda, MD, PhD
Fundación para la Investigación Biomédica del Hospital 12 de Octubre
Intervention
Valganciclovir Oral Solution [Valcyte](drug)
Enrollment
563 target
Eligibility
All sexes
Timeline
2020 – 2025

Study locations (13)

Collaborators

University Hospital, Bordeaux · Institut National de la Santé Et de la Recherche Médicale, France · PENTA Foundation · Centre Hospitalier Cocody · Malawi-Liverpool-Wellcome Trust Clinical Research Programme · Eduardo Mondlane University · Centro de Investigação em Saúde de Manhiça · Stichting Katholieke Universiteit · Barcelona Institute for Global Health · University of Lincoln · Makerere University · University Teaching Hospital, Lusaka, Zambia · University of Zimbabwe · Kamuzu Central Hospital · Servicio Madrileño de Salud, Madrid, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03915366 on ClinicalTrials.gov

Other trials for Primary genito-urinary tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Primary genito-urinary tuberculosis →

← Back to all trials